The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Reversal of Hepatic Fibrosis — Fact or Fantasy?
Abstract
The prospect of reversing hepatic fibrosis has generated great interest now that basic science advances are being translated into promising new antifibrotic therapies. It is appropriate to recognize both the historical advances that created the framework for these successes, and the important role that Hepatology has played in disseminating them. A sense of urgency underlies this effort as the epidemics of HCV and NASH are becoming associated with advancing fibrosis. To maintain progress and minimize confusion among investigators and clinicians it is essential to standardize terms referring to fibrosis ‘reversal’ and ‘regression.’ There must also be rapid optimization of non-invasive markers of fibrosis to relieve this current bottleneck to conducting clinical trials. Progress in identifying genetic determinants of fibrosis could further refine patient selection for clinical trials and shorten their duration, as well as unearthing new directions of scientific inquiry. Realistic expectations for successful anti-fibrotic therapies reflect solid evidence of fibrosis regression in patients treated effectively for viral liver disease, as well as growing clarity in the understanding mechanisms of extracellular matrix production and degradation. The paradigms of stellate cell activation and apoptosis remain valuable frameworks for understanding pathways of hepatic fibrogenesis and fibrosis regression, respectively. Continued progress is essential in order to identify the determinants and dynamics of fibrosis reversibility, to discover additional targets for anti-fibrotic therapy, and to develop customized multi-drug regimens. These advances are sure to be captured in the next 25 years by Hepatology, and to profoundly impact the prognosis of patients with chronic liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bedossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,376
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04396-4 · Cited by 2,093
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Poynard, T., McHutchison, J., Manns, M., Trepo, C., Lindsay, K., Goodman, Z., Ling, M., & Albrecht, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33023 · Cited by 1,146
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Shiratori, Y., Imazeki, F., Moriyama, M., Yano, M., Arakawa, Y., Yokosuka, O., Kuroki, T., Nishiguchi, S., Sata, M., Yamada, G., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00002 · Cited by 733
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
Histological outcome during long-term lamivudine therapy
Dienstag, J. L., Goldin, R. D., Heathcote, E. J., Hann, H. W. L., Woessner, M., Stephenson, S. L., Gardner, S., Gray, D. F., & Schiff, E. R. (2003) · Gastroenterology · doi:10.1053/gast.2003.50013 · Cited by 726
Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
Friedman, S. L. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0055 · Cited by 498
Self-citationHepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis
Bataller, R., & Brenner, D. A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17558 · Cited by 492
Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells
Benyon, R. C., & Arthur, M. J. P. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17552 · Cited by 485
Issa, R., Zhou, X., Constandinou, C. M., Fallowfield, J., Millward-Sadler, H., Gaca, M. D. A., Sands, E., Suliman, I., Trim, N., & Knorr, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.009 · Cited by 456
Murphy, F. R., Issa, R., Zhou, X., Ratnarajah, S., Arthur, M. J. P., Benyon, C., Iredale, J. P., & Nagase, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111490200 · Cited by 432
Hammel, P., Couvelard, A., O'Toole, D., Ratouis, A., Sauvanet, A., Fléjou, J. F., Degott, C., Belghiti, J., Bernades, P., Valla, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440604 · Cited by 427
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
Villeneuve, J.-P., Condreay, L. D., Willems, B., Pomier-Layrargues, G., Fenyves, D., Bilodeau, M., Leduc, R., Peltekian, K., Wong, F., Margulies, M., et al. (2000) · Hepatology · doi:10.1002/hep.510310130 · Cited by 410
Roles of TGF-beta in hepatic fibrosis
Gressner, A. (2002) · Frontiers in Bioscience · doi:10.2741/gressner · Cited by 405
Host genetic factors influence disease progression in chronic hepatitis C
Powell, E. E., Edwards-Smith, C. J., Hay, J. L., Clouston, A. D., Crawford, D. H., Shorthouse, C., Purdie, D. M., & Jonsson, J. R. (2000) · Hepatology · doi:10.1053/he.2000.6253 · Cited by 398
Genetic Polymorphisms and the Progression of Liver Fibrosis: A Critical Appraisal
Bataller, R., North, K. E., & Brenner, D. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50127 · Cited by 355
Regression of Human Cirrhosis: Morphologic Features and the Genesis of Incomplete Septal Cirrhosis
Wanless, I. R., Nakashima, E., & Sherman, M. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-1599-rohc · Cited by 339
Hepatic Stellate Cell Behavior during Resolution of Liver Injury
Iredale, J. P. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17557 · Cited by 333
Purified Rat Liver Fat-Storing Cells in Culture Divide and Contain Collagen
De Margreet Leeuw, A., Mccarthy, S. P., Geerts, A., & Knook, D. L. (1984) · Hepatology · doi:10.1002/hep.1840040307 · Cited by 326
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322
Farci, P., Roskams, T., Chessa, L., Peddis, G., Mazzoleni, A. P., Scioscia, R., Serra, G., Lai, M. E., Loy, M., & Caruso, L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.017 · Cited by 294
Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis
Dufour, J.-F., DeLellis, R., & Kaplan, M. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00006 · Cited by 290
Popper, H., & Udenfriend, S. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80135-8 · Cited by 282
Oakley, F., Meso, M., Iredale, J. P., Green, K., Marek, C. J., Zhou, X., May, M. J., Millward-Sadler, H., Wright, M. C., & Mann, D. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.003 · Cited by 265
Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat
Iimuro, Y., Nishio, T., Morimoto, T., Nitta, T., Stefanovic, B., Choi, S. K., Brenner, D. A., & Yamaoka, Y. (2003) · Gastroenterology · doi:10.1053/gast.2003.50063 · Cited by 263
Yoshiji, H., Kuriyama, S., Miyamoto, Y., Thorgeirsson, U. P., Gomez, D. E., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Tsujinoue, H., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.20521 · Cited by 252
Cirrhosis reversal: a duel between dogma and myth
Desmet, V. J., & Roskams, T. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.007 · Cited by 247
Magness, S. T., Bataller, R., Yang, L., & Brenner, D. A. (2004) · Hepatology · doi:10.1002/hep.20427 · Cited by 246
PDGF and signal transduction in hepatic stellate cells
Pinzani, M. (2002) · Frontiers in Bioscience · doi:10.2741/a875 · Cited by 239
Natural history of hepatitis C
Seeff, L. B. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00374-5 · Cited by 239
The Principles of Pathologic Histology
Mallory, F. B. (1915) · Southern Medical Journal · doi:10.1097/00007611-191502000-00032 · Cited by 236
Issa, R., Zhou, X., Trim, N., Millward‐Sadler, H., Krane, S., Benyon, C., & Iredale, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0494fje · Cited by 208
Cirrhosis: new research provides a basis for rational and targeted treatments
Iredale, J. P. (2003) · BMJ · doi:10.1136/bmj.327.7407.143 · Cited by 192
Liu, C., Gaça, M. D. A., Swenson, E. S., Vellucci, V. F., Reiss, M., & Wells, R. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207728200 · Cited by 186
Bonis, P. A. L., Friedman, S. L., & Kaplan, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440610 · Cited by 174
Self-citationTreatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis
Siller-López, F., Sandoval, A., Salgado, S., Salazar, A., Bueno, M., Garcia, J., Vera, J., Gálvez, J., Hernández, I., & Ramos, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.045 · Cited by 173
Kweon, Y.-O., Goodman, Z. D., Dienstag, J. L., Schiff, E. R., Brown, N. A., Burkhardt, E., Schoonhoven, R., Brenner, D. A., & Fried, M. W. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00218-5 · Cited by 167
Han, Y., Zhou, L., Wang, J., Xiong, S., Garner, W. L., French, S. W., & Tsukamoto, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310999200 · Cited by 155
Collagenase activity in experimental hepatic fibrosis
Okazaki, I., & Maruyama, K. (1974) · Nature · doi:10.1038/252049a0 · Cited by 143
Nuclear Factor-κB1 (p50) Limits the Inflammatory and Fibrogenic Responses to Chronic Injury
Oakley, F., Mann, J., Nailard, S., Smart, D. E., Mungalsingh, N., Constandinou, C., Ali, S., Wilson, S. J., Millward-Sadler, H., Iredale, J. P., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62291-2 · Cited by 123
Hepatocytes Express Nerve Growth Factor during Liver Injury
Oakley, F., Trim, N., Constandinou, C. M., Ye, W., Gray, A., Frantz, G. D., Hillan, K. J., Kendall, T. J., Benyon, R. C., Mann, D. A., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63544-4 · Cited by 113
Cirrhosis of the liver: a reversible disease?
Pérez-Tamayo, R. (1979) · PubMed · Cited by 109
Zhou, X., Hovell, C. J., Pawley, S., Hutchings, M. I., Arthur, M. J. P., Iredale, J. P., & Benyon, R. C. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0946.x · Cited by 108
Lysyl Oxidase: Mechanism, Regulation and Relationship to Liver Fibrosis
Kagan, H. M. (1994) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80995-7 · Cited by 108
Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation
Muretto, P., Angelucci, E., & Lucarelli, G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-9-200205070-00009 · Cited by 102
Risk factors for liver fibrosis progression in patients with chronic hepatitis C
de Torres, M., & Poynard, T. (2003) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32152-0 · Cited by 80
Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat.
Siegel, R. C., Chen, K. H., Greenspan, J. S., & Aguiar, J. M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2945 · Cited by 77
Expression of Smads during in Vitro Transdifferentiation of Hepatic Stellate Cells to Myofibroblasts
Dooley, S., Streckert, M., Delvoux, B., & Gressner, A. M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4811 · Cited by 74
Conversion of Micronodular Cirrhosis into Macronodular Cirrhosis
Fauerholdt, L., Schlichting, P., Christensen, E., Poulsen, H., Tygstrup, N., & Juhl, E. (1983) · Hepatology · doi:10.1002/hep.1840030607 · Cited by 71
Hepatic fibrosis: From bench to bedside
Schuppan, D., & POROV, Y. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s3.18.x · Cited by 67
Collagen Production by Rat Hepatocytes and Sinusoidal Cells in Primary Monolayer Culture†
Tseng, S. C. G., Lee, P. C., Ells, P. F., Bissell, D. M., Smuckler, E. A., & Stern, R. (1982) · Hepatology · doi:10.1002/hep.1840020104 · Cited by 67
Targeted treatments for cirrhosis
Fallowfield, J. A., & Iredale, J. P. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.423 · Cited by 67
Voß, B., Rauterberg, J., Pott, G., Brehmer, U., Allam, S., Lehmann, R., & Bassewitz, D. B. V. (1982) · Hepatology · doi:10.1002/hep.1840020105 · Cited by 56
Prevalence of Hepatitis C–Related Cirrhosis in Elderly Asian Patients Infected in Childhood
D'Souza, R., Glynn, M. J., Ushiro‐Lumb, I., Feakins, R. M., Domizio, P., Mears, L., ALSCED, E., KUMAR, P., Sabin, C. A., & Foster, G. R. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00527-6 · Cited by 43
Takahashi, S., & Simpser, E. F. (1981) · Hepatology · doi:10.1002/hep.1840010304 · Cited by 25
Proline trapping in granulomas, the site of collagen biosynthesis in murine schistosomiasis
Dunn, M. A., Seifter, S., & Hait, P. K. (1981) · Hepatology · doi:10.1002/hep.1840010105 · Cited by 15
A cut above the rest? MMP-8 and liver fibrosis gene therapy
Iredale, J. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.060 · Cited by 13
Schnabel, C. (2004) · Hepatology Research · doi:10.1016/j.hepres.2003.11.004 · Cited by 10
Cited by
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citationPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Self-citationAssessment of Hepatic Fibrosis With Magnetic Resonance Elastography
Yin, M., Talwalkar, J. A., Glaser, K. J., Manduca, A., Grimm, R. C., Rossman, P. J., Fidler, J. L., & Ehman, R. L. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.06.012 · Cited by 948
The pancreatic stellate cell: a star on the rise in pancreatic diseases
Omary, M. B., Lugea, A., Lowe, A. W., & Pandol, S. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30082 · Cited by 692
Magnetic resonance elastography of liver: Technique, analysis, and clinical applications
Venkatesh, S. K., Yin, M., & Ehman, R. L. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23731 · Cited by 659
Metadata
- Authors
- Friedman, S. L., & Bansal, M. B.
- Venue
- Hepatology
- Published
- 2006-02
- Volume
- 43
- Issue
- Supplement 1
- Pages
- S82-S88
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2038774859
- Cited by
- 379
- References
- 69
- FWCI
- 20.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.